Oral Chinese Herbal Medicine for Psoriasis Vulgaris With Blood Heat Syndrome

Exclusion Criteria

• •1. Patients with erythrodermic, arthritic, pustular or punctate psoriasis;
• •2. Other active skin diseases may affect the condition assessment;
• •3. Received research drugs, biological agents and immunosuppressive agents within 1 month;
• •4. 2 weeks of treatment with topical glucocorticoids, phototherapy, etc.;
• •5. During severe, uncontrollable local or systemic acute or chronic infections;
• •6. Patients with severe systemic diseases; or clinical test indicators in one of the following conditions: alanine aminotransferase or aspartate aminotransferase increased by \>1.5 times the upper limit of normal; creatinine increased by 1.5 times the upper limit of normal; blood routine indicators (white blood cell count) Any one of the red blood cell count, hemoglobin amount, and platelet count) is below the lower limit of normal; or other laboratory abnormalities are judged by the investigator to be unsuitable for participation in the trial;
• •7. A history of malignant tumors and patients with primary or secondary immunodeficiency and hypersensitivity;
• •8. Such surgery will be required during major surgery or study during 8 weeks;
• •9. Pregnant or lactating women;
• •10. A person with a history of alcohol abuse, drug abuse or drug abuse;
• •11. Have a history of serious mental illness or family history;
• •12. Other reasons researchers believe that it is inappropriate to participate in this research.